<DOC>
	<DOCNO>NCT02606760</DOCNO>
	<brief_summary>The purpose study confirm clinical efficacy safety P-3073 patient affect isolated psoriatic nail ( ) and/or psoriatic nail concomitant mild moderate plaque psoriasis .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety P-3073 Nail Solution Treatment Nails Affected Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Written inform consent start study related procedure Patients age 18 80 year old race . Males female . Patients mild moderate psoriastic fingernail ( ) define fingernail/s matrix psoriasis NAPSI score and/or bed psoriasis NAPSI score ≥ 1 ≤ 3 baseline . In case skin involvement , patient establish clinical diagnosis mildtomoderate psoriasis ( BSA involvement ≤ 8 % PASI ≤ 10 ) Woman pregnant , nursing infant , plan pregnancy study period . Use systemic treatment psoriasis last six month screen visit . Use photochemotherapy form radiotherapy last four week screen visit . Positive mycology finding Systemic use immunosuppressive , chemotherapy corticosteroid last three month screen visit . Consumption Vitamin D analogue last three month . History hypercalcaemia hypercalciuria . HIV infection immunodeficiency . Alcohol substance abuse . Patients history allergic reaction calcipotriol excipients .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Nail psoriasis</keyword>
</DOC>